biopharmapatent
Monday, July 17, 2017
FDA’s Committee Recommends Approval of Mylan's Herceptin and Amgen's Avastin Biosimilars
https://www.bloomberg.com/gadfly/articles/2017-07-13/fda-vote-for-avastin-herceptin-biosimilars-no-disaster-for-roche
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment